MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
Beckley Foundation
Fri, Sep 15
Nature Medicine - Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms and functional impairment in a...